Trump’s Drug-Pricing Push to Cut Access Outside US, Study Finds

A study found that the Trump administration's push to lower US drug spending is a powerful incentive for pharmaceutical companies to raise prices and reduce access in other countries. The policy may cut costs domestically but could harm global access to medicines.